Large review finds no clinically important effect of glucosamine or chondroitin on pain in people with osteoarthritis of the knee or hip but results are questionable and likely due to heterogeneity

Evidence-Based Medicine

Volumn 16, Issue 2, 2011, Pages 52-53

  Bruyère, Olivier ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN; GLUCOSAMINE; GLUCOSAMINE SULFATE;

ARTHRALGIA; DRUG EFFECT; HIP OSTEOARTHRITIS; HUMAN; JOINT CAVITY; KNEE OSTEOARTHRITIS; META ANALYSIS; NOTE; PATIENT SAFETY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE;

EID: 79953069863     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebm1164     Document Type: Note

References (3)

1. Reginster JY. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. Arthritis Rheum 2007;56:2105-10.
2. Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476-99.
3. Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthr Cartil 2008;16:254-60. (Pubitemid 351218188)